Literature DB >> 14724158

Antibiotic use and the development of Crohn's disease.

T Card1, R F A Logan, L C Rodrigues, J G Wheeler.   

Abstract

BACKGROUND: Few environmental determinants of Crohn's disease are well established. Some observational data exist to implicate antibiotic use as a risk factor but these are derived from studies using questionnaires to assess reported antibiotic use that were susceptible to recall bias. We have therefore explored this relationship in prospectively gathered data.
METHODS: We selected incident cases of Crohn's disease from the General Practice Research Database with at least five years of data prior to diagnosis. Controls with five years of complete data were randomly selected. Data were extracted on smoking, drug prescriptions, age, sex, and a variety of symptoms and diagnoses that might be indicative of occult Crohn's disease. Logistic regression was used to investigate the relationship between antibiotic use and Crohn's disease.
RESULTS: A total of 587 Crohn's disease cases and 1460 controls were available for analysis. We found that antibiotic use 2-5 years pre-diagnosis occurred in 71% of cases compared with 58% of controls (p<0.001), and the median number of courses was two in the cases and one in the controls (p<0.001). Adjusting for age, sex, smoking, and use of other drugs, antibiotic use had an odds ratio of 1.32 (1.05-1.65). We were unable to show specificity to any subgroup of antibacterials. Associations similar to that with antibiotics were also found with oral contraceptive, cardiovascular, and neurological drugs.
CONCLUSIONS: We found a statistically significant association between Crohn's disease and prior antibiotic use. This cannot be explained by recall bias, but due to lack of specificity it is unclear whether it is causal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724158      PMCID: PMC1774910          DOI: 10.1136/gut.2003.025239

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC).

Authors:  G Corrao; A Tragnone; R Caprilli; G Trallori; C Papi; A Andreoli; M Di Paolo; G Riegler; G P Rigo; O Ferraù; C Mansi; M Ingrosso; D Valpiani
Journal:  Int J Epidemiol       Date:  1998-06       Impact factor: 7.196

Review 2.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

3.  Inflammatory bowel disease incidence: up, down or unchanged?

Authors:  R F Logan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

4.  The General Practice Research Database: quality of morbidity data.

Authors:  J Hollowell
Journal:  Popul Trends       Date:  1997

5.  The Read clinical classification.

Authors:  J Chisholm
Journal:  BMJ       Date:  1990-04-28

6.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

7.  Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.

Authors:  P G Godet; G R May; L R Sutherland
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  The VAMP Research multi-purpose database in the U.K.

Authors:  Y Lis; R D Mann
Journal:  J Clin Epidemiol       Date:  1995-03       Impact factor: 6.437

Review 9.  Is Crohn's disease caused by antibiotics?

Authors:  L Demling
Journal:  Hepatogastroenterology       Date:  1994-12

10.  Childhood infections and the risk of inflammatory bowel disease.

Authors:  J I Wurzelmann; C M Lyles; R S Sandler
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

View more
  48 in total

Review 1.  Will worms really cure Crohn's disease?

Authors:  G L Radford-Smith
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 2.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 3.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Authors:  Natasha-A Koloski; Laurel Bret; Graham Radford-Smith
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

4.  Antibiotic use and the risk of Crohn's disease.

Authors:  Charles N Bernstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

5.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

Review 6.  [Chronic inflammatory intestinal diseases. Pathophysiology and therapy].

Authors:  K Herrlinger; B Wittig; E F Stange
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

Review 7.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

8.  Antibiotics promote inflammation through the translocation of native commensal colonic bacteria.

Authors:  Kathryn A Knoop; Keely G McDonald; Devesha H Kulkarni; Rodney D Newberry
Journal:  Gut       Date:  2015-06-04       Impact factor: 23.059

9.  Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.

Authors:  Femke-Anouska Heinsen; Henrik Knecht; Sven C Neulinger; Ruth A Schmitz; Carolin Knecht; Tanja Kühbacher; Philip C Rosenstiel; Stefan Schreiber; Anette K Friedrichs; Stephan J Ott
Journal:  Gut Microbes       Date:  2015-07-04

10.  Genetic and environmental factors drive personalized medicine for Crohn's disease.

Authors:  Shigeru Oshima; Mamoru Watanabe
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.